STERIS plc Ordinary Shares (STE) was Upgraded by Northcoast to ” Buy”. Earlier the firm had a rating of “Neutral ” on the company shares. Northcoast advised their investors in a research report released on Jun 3, 2016.
On the company’s financial health, STERIS plc Ordinary Shares reported $0.90 EPS for the quarter, missing the analyst consensus estimate by $ -0.14 based on the information available during the earnings call on May 18, 2016. Analyst had a consensus of $1.04. The company had revenue of $690.30 million for the quarter, compared to analysts expectations of $702.44 million. The company’s revenue was up 37.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.98 EPS.
STERIS plc Ordinary Shares opened for trading at $69.36 and hit $70.05 on the upside on Wednesday, eventually ending the session at $69.72, with a gain of 0.42% or 0.29 points. The heightened volatility saw the trading volume jump to 6,63,603 shares. Company has a market cap of $5,989 M.
Investors should note that on May 18, 2016, STERIS plc Ordinary Shares announced a cash dividend of $0.2500. The company’s management has announced Jun 6, 2016 as the ex-dividend date and fixed the record date on Jun 8, 2016. The payable date has been fixed on Jun 29, 2016.
In a different news, on Feb 18, 2016, Walter M Jr Rosebrough (President & CEO) sold 10,000 shares at $64.27 per share price. According to the SEC, on Nov 10, 2015, Kathleen Bardwell (Sr.V. P. & C.C.O.) sold 2,496 shares at $74.21 per share price. On Nov 10, 2015, Kevin M Mcmullen (director) sold 8,000 shares at $74.42 per share price, according to the Form-4 filing with the securities and exchange commission.